Heartland Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-171,222
| Closed | -$5.3M | – | 212 |
|
|
2020
Q1 | $5.3M | Sell |
171,222
-34,500
| -17% | -$1.18M | 0.57% | 74 |
|
|
2019
Q4 | $7.65M | Sell |
205,722
-121,313
| -37% | -$4.32M | 0.56% | 77 |
|
|
2019
Q3 | $11.1M | Buy |
327,035
+15,059
| +5% | +$548K | 0.85% | 34 |
|
|
2019
Q2 | $12.8M | Sell |
311,976
-2,659
| -0.8% | -$106K | 0.94% | 26 |
|
|
2019
Q1 | $12.7M | Sell |
314,635
-3,084
| -1% | -$124K | 0.94% | 24 |
|
|
2018
Q4 | $13.2M | Sell |
317,719
-2,152
| -0.7% | -$89.3K | 1.09% | 16 |
|
|
2018
Q3 | $13.4M | Sell |
319,871
-3,164
| -1% | -$122K | 0.89% | 28 |
|
|
2018
Q2 | $11.1M | Buy |
323,035
+9,715
| +3% | +$332K | 0.73% | 45 |
|
|
2018
Q1 | $10.6M | Buy |
313,320
+2,958
| +1% | +$102K | 0.71% | 44 |
|
|
2017
Q4 | $10.7M | Sell |
310,362
-236
| -0.1% | -$8.05K | 0.69% | 55 |
|
|
2017
Q3 | $10.5M | Buy |
310,598
+75,411
| +32% | +$2.42M | 0.68% | 59 |
|
|
2017
Q2 | $7.5M | Sell |
235,187
-4,290
| -2% | -$135K | 0.48% | 98 |
|
|
2017
Q1 | $7.77M | Sell |
239,477
-9,443
| -4% | -$298K | 0.47% | 97 |
|
|
2016
Q4 | $7.67M | Buy |
248,920
+32,225
| +15% | +$984K | 0.42% | 108 |
|
|
2016
Q3 | $6.96M | Buy |
216,695
+21,682
| +11% | +$725K | 0.4% | 107 |
|
|
2016
Q2 | $6.51M | Sell |
195,013
-7,215
| -4% | -$230K | 0.37% | 109 |
|
|
2016
Q1 | $5.69M | Sell |
202,228
-227,135
| -53% | -$6.49M | 0.3% | 126 |
|
|
2015
Q4 | $13.2M | Sell |
429,363
-94,028
| -18% | -$2.96M | 0.53% | 65 |
|
|
2015
Q3 | $15.6M | Sell |
523,391
-10,072
| -2% | -$323K | 0.57% | 54 |
|
|
2015
Q2 | $17M | Sell |
533,463
-225,006
| -30% | -$7.33M | 0.47% | 75 |
|
|
2015
Q1 | $25M | Sell |
758,469
-176,638
| -19% | -$5.62M | 0.63% | 51 |
|
|
2014
Q4 | $27.6M | Buy |
935,107
+55,420
| +6% | +$1.59M | 0.54% | 70 |
|
|
2014
Q3 | $24.7M | Sell |
879,687
-13,943
| -2% | -$391K | 0.48% | 79 |
|
|
2014
Q2 | $25.2M | Buy |
893,630
+113,362
| +15% | +$3.23M | 0.44% | 86 |
|
|
2014
Q1 | $23.8M | Buy |
780,268
+29,093
| +4% | +$867K | 0.42% | 89 |
|
|
2013
Q4 | $21.8M | Sell |
751,175
-3,399
| -0.5% | -$98.9K | 0.38% | 99 |
|
|
2013
Q3 | $20.6M | Sell |
754,574
-11,145
| -1% | -$303K | 0.37% | 102 |
|
|
2013
Q2 | $20.3M | Buy |
+765,719
| New | +$21.2M | 0.38% | 106 |
|
Other funds holding PFE
Heartland Advisors's PFE Position: Q2 2020 in Review
Heartland Advisors sold out of Pfizer (PFE) in Q2 2020, closing a stake of 171,222 shares — an estimated $5.3M sold.
Heartland Advisors first reported a position in PFE in Q2 2013 and held it in 28 quarters. The position peaked at $27.6M in Q4 2014. 2,441 funds tracked by Wall St. Rank hold PFE as of Q2 2020.
- Heartland Advisors reported no remaining Pfizer position as of Q2 2020 after selling out during the quarter.
- Heartland Advisors sold 171,222 Pfizer shares in Q2 2020, an estimated $5.3M.
- Heartland Advisors first reported a position in Pfizer in Q2 2013 and held it in 28 quarters.
- Heartland Advisors's Pfizer position peaked at $27.6M in Q4 2014.
- 2,441 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.
Based on Heartland Advisors's 13F filing for Q2 2020, filed 12 Aug 2020.